300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Social Impact
Artificial Intelligence
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Payments
Retail
Film
Organic Food
Marketplace
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Facebook
Blockchain
Social Network
Medical Device
Education
Sports
Wellness
Biotechnology
Automotive
eSports
Software
Legal
Renewable Energy
Crowdfunding
Recruiting
Venture Capital
Web3
Medical
Theatre
Climate
Social
LGBT
Cannabis
Infrastructure
Celebrity
Life Science
Food and Beverage
Beauty
Publishing
Mobile Apps
Wine and Spirits
Fashion
Music
Manufacturing
Art
FinTech
Real Estate
Sporting Goods
Finance
Social Media
Financial Services
Digital Media
Franchise
Non Profit
Android
Proptech
Impact
Sustainability
Internet
Hardware
Biotech
Transportation
Mobile Advertising
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Hong Kong
Tunisia
Sweden
Oceania
Nigeria
Togo
Croatia
Guinea
Iran
Haiti
Lesotho
Kyrgyzstan
Isle of Man
Norway
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Tajikistan
Pakistan
Zambia
Romania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Turkey
Uruguay
Uganda
Seychelles
Moldova
Botswana
Paraguay
Canada
South Africa
Ireland
France
Denmark
Ghana
Georgia
Iraq
Latvia
Mali
Malaysia
Philippines
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
Portugal
India
United States
Germany
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Spain
Albania
Argentina
Bangladesh
Barbados
Belgium
Europe
Jordan
Qatar
Ethiopia
Austria
Azerbaijan
Bulgaria
Angola
Cyprus
Ecuador
Faroe Islands
Jersey
Bahrain
Bolivia
Estonia
Bahamas
Belize
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Algeria
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Noble Resources, VC Fund

Noble Resources

VC Fund

Wan Chai, Hong Kong

Noble Resources is a VC fund in Wan Chai focused on Medical and Health Care. Noble Group is a global supply chain manager of energy, power & gas products, metals and carbon steel materials, with interests in key facilities that add value at various stages of its supply chains. Noble Group manages a diversified portfolio of essential natural resources, with integrated sourcing, marketing, processing, financing andtransportation operations. Noble Group's Energy segment encompasses a portfolio of oil liquids and coal products and continues to be a significant driver for the Group’s growth. Gas & Power segment includes their retail energy business Noble Americas Energy Solutions and Gas & Power wholesale operations. In Metals & Mining, Noble Group is one of the world’s leading suppliers with interests in iron ore, aluminium, special ores and alloys across key global locations. The Corporate segment incorporates the Logistics business as well as investments in their major associates. Noble Group (SGX: N21) manages a portfolio of global supply chains covering a range of industrial and energy products. Operating from over 60 locations, Noble facilitates the marketing, processing, financing and transportation of essential raw materials. Sourcing bulk commodities from low cost regions such as South America, South Africa, Australia and Indonesia, the Group supplies high growth demand markets, particularly in Asia and the Middle East. Noble Group is ranked number 77 in the 2015 Fortune Global 500. Noble moves essential resources from producers to consumer across the world. Noble Group's success relies on a rigorously managed balance sheet, effective partnerships and a deep understanding of customer needs. Noble’s core strategy is to be the best company in the world at moving the physical commodity from the producer to the consumer and managing the market, credit and operational risk associated with that. Noble Group's solid financial position comes from a rigorously managed balance sheet with exceptional liquidity and a carefully guided exposure to risk - underpinned by deep relationships with global capital providers. At Noble, they have forged some of the most productive and enterprising partnerships in the industry and they have always believed that as their partners grow, so do they. Noble Group put energy and focus into staying relevant and being valuable to their customers, keeping their interests firmly integrated into their DNA.

Total investments:
2
Last investment:
Lead investor:
0%

Last updated:

Industries Noble Resources invests in

MedicalHealth CareGeneticsLife ScienceBiotechnology

Stages Noble Resources invests in

Funding Round

Countries Noble Resources invests in

DenmarkUnited Kingdom

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Medical 2 (100%)
  • Health Care 2 (100%)
  • Genetics 1 (50%)
  • Life Science 1 (50%)
  • Biotechnology 1 (50%)
See all 7 industries →

Country

  • Denmark 1 (50%)
  • United Kingdom 1 (50%)

Team

NameTitleInvestmentsLinksEmail
Jacques Erni
Jacques Erni Group Chief Financial Officer
Group Chief Financial Officer Total investments: 0 Find email

Investments

CompanyDescriptionRoundLinks
Digital Healthcare is a health care company. The company has been acquired by EMIS Group. $3.4M / Dec 09, 2008
Exiqon operates in two business areas: Life Sciences and Diagnostics. Exiqon Life Sciences, a leading provider of flexible solutions for RNA analysis. Exiqon’s research products are used by academia, biotech and pharmaceutical companies around the world to make groundbreaking discoveries about the correlation between gene activity and thedevelopment of cancer and other diseases. Exiqon Diagnostics collaborates with pharmaceutical and diagnostic companies to develop novel molecular diagnostic tests for early detection of diseases which can help physicians make treatment decisions based on the tools developed by Exiqon Life Sciences. $20M / Jun 03, 2005

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Social Impact
Artificial Intelligence
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Payments
Retail
Film
Organic Food
Marketplace
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Facebook
Blockchain
Social Network
Medical Device
Education
Sports
Wellness
Biotechnology
Automotive
eSports
Software
Legal
Renewable Energy
Crowdfunding
Recruiting
Venture Capital
Web3
Medical
Theatre
Climate
Social
LGBT
Cannabis
Infrastructure
Celebrity
Life Science
Food and Beverage
Beauty
Publishing
Mobile Apps
Wine and Spirits
Fashion
Music
Manufacturing
Art
FinTech
Real Estate
Sporting Goods
Finance
Social Media
Financial Services
Digital Media
Franchise
Non Profit
Android
Proptech
Impact
Sustainability
Internet
Hardware
Biotech
Transportation
Mobile Advertising
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Hong Kong
Tunisia
Sweden
Oceania
Nigeria
Togo
Croatia
Guinea
Iran
Haiti
Lesotho
Kyrgyzstan
Isle of Man
Norway
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Tajikistan
Pakistan
Zambia
Romania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Turkey
Uruguay
Uganda
Seychelles
Moldova
Botswana
Paraguay
Canada
South Africa
Ireland
France
Denmark
Ghana
Georgia
Iraq
Latvia
Mali
Malaysia
Philippines
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
Portugal
India
United States
Germany
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Spain
Albania
Argentina
Bangladesh
Barbados
Belgium
Europe
Jordan
Qatar
Ethiopia
Austria
Azerbaijan
Bulgaria
Angola
Cyprus
Ecuador
Faroe Islands
Jersey
Bahrain
Bolivia
Estonia
Bahamas
Belize
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Algeria
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Noble Resources invest in?

Noble Resources invests primarily in Medical, Health Care and Genetics startups, most often at Funding Round stage. Most of the 2 investments tracked by Shizune back companies in Denmark. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Noble Resources?

Public channels for Noble Resources include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Noble Resources?

The team at Noble Resources includes Jacques Erni (Group Chief Financial Officer). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Noble Resources Noble Resources Find emails